| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Exit | BIONOMICS LIMITEDads | $0 | – | -47,372 | -100.0% | -0.00% | – | |
| RZLT | Exit | REZOLUTE INC | $0 | – | -190,815 | -100.0% | -0.01% | – |
| ELEV | Exit | ELEVATION ONCOLOGY INC | $0 | – | -2,312,200 | -100.0% | -0.04% | – |
| IMUX | Exit | IMMUNIC INC | $0 | – | -1,149,425 | -100.0% | -0.05% | – |
| MOLN | Exit | MOLECULAR PARTNERS AGads | $0 | – | -443,221 | -100.0% | -0.05% | – |
| Exit | ASLAN PHARMACEUTICALS LTDspon ads new | $0 | – | -1,049,999 | -100.0% | -0.05% | – | |
| FBRX | Exit | FORTE BIOSCIENCES INC | $0 | – | -2,982,105 | -100.0% | -0.05% | – |
| CRVS | Exit | CORVUS PHARMACEUTICALS INC | $0 | – | -1,370,947 | -100.0% | -0.05% | – |
| IVA | Exit | INVENTIVA SAads | $0 | – | -686,040 | -100.0% | -0.08% | – |
| Exit | UNICYCIVE THERAPEUTICS INC | $0 | – | -3,413,563 | -100.0% | -0.08% | – | |
| RAIN | Exit | RAIN ONCOLOGY INC | $0 | – | -3,526,729 | -100.0% | -0.08% | – |
| Exit | MOLECULAR TEMPLATES INC | $0 | – | -532,038 | -100.0% | -0.09% | – | |
| VIRX | Exit | VIRACTA THERAPEUTICS INC | $0 | – | -3,614,662 | -100.0% | -0.10% | – |
| KRON | Exit | KRONOS BIO INC | $0 | – | -2,905,043 | -100.0% | -0.10% | – |
| DCTH | Exit | DELCATH SYS INC | $0 | – | -976,149 | -100.0% | -0.11% | – |
| NLSP | Exit | NLS PHARMACEUTICS LTD | $0 | – | -5,747,126 | -100.0% | -0.11% | – |
| ELDN | Exit | ELEDON PHARMACEUTICALS INC | $0 | – | -4,326,710 | -100.0% | -0.16% | – |
| PIRS | Exit | PIERIS PHARMACEUTICALS INC | $0 | – | -20,609,863 | -100.0% | -0.17% | – |
| CDTX | Exit | CIDARA THERAPEUTICS INC | $0 | – | -6,861,127 | -100.0% | -0.17% | – |
| Exit | JASPER THERAPEUTICS INC | $0 | – | -9,900,000 | -100.0% | -0.19% | – | |
| Exit | TSCAN THERAPEUTICS INC | $0 | – | -2,989,474 | -100.0% | -0.21% | – | |
| CTMX | Exit | CYTOMX THERAPEUTICS INC | $0 | – | -6,595,801 | -100.0% | -0.23% | – |
| VERV | Exit | VERVE THERAPEUTICS INC | $0 | – | -650,000 | -100.0% | -0.23% | – |
| Exit | VIGIL NEUROSCIENCE INC | $0 | – | -1,813,633 | -100.0% | -0.26% | – | |
| IMVT | Exit | IMMUNOVANT INC | $0 | – | -300,000 | -100.0% | -0.31% | – |
| STRO | Exit | SUTRO BIOPHARMA INC | $0 | – | -3,347,946 | -100.0% | -0.31% | – |
| CALT | Exit | CALLIDITAS THERAPEUTICS ABsponsered ads | $0 | – | -750,000 | -100.0% | -0.37% | – |
| Exit | VERASTEM INC | $0 | – | -1,685,219 | -100.0% | -0.37% | – | |
| IKNA | Exit | IKENA ONCOLOGY INC | $0 | – | -3,169,164 | -100.0% | -0.37% | – |
| ITOS | Exit | ITEOS THERAPEUTICS INC | $0 | – | -1,259,476 | -100.0% | -0.37% | – |
| Exit | NEWAMSTERDAM PHARMA COMPANYordinary shares | $0 | – | -1,521,948 | -100.0% | -0.38% | – | |
| GLYC | Exit | GLYCOMIMETICS INC | $0 | – | -9,544,262 | -100.0% | -0.39% | – |
| SLN | Exit | SILENCE THERAPEUTICS PLCads | $0 | – | -1,508,416 | -100.0% | -0.40% | – |
| ALLK | Exit | ALLAKOS INC | $0 | – | -8,552,417 | -100.0% | -0.52% | – |
| RLAY | Exit | RELAY THERAPEUTICS INC | $0 | – | -2,365,805 | -100.0% | -0.54% | – |
| ACIU | Exit | AC IMMUNE SA | $0 | – | -7,428,379 | -100.0% | -0.57% | – |
| LXRX | Exit | LEXICON PHARMACEUTICALS INC | $0 | – | -19,995,332 | -100.0% | -0.59% | – |
| Exit | AN2 THERAPEUTICS INC | $0 | – | -1,563,963 | -100.0% | -0.68% | – | |
| OVID | Exit | OVID THERAPEUTICS INC | $0 | – | -6,851,051 | -100.0% | -0.71% | – |
| EPIX | Exit | ESSA PHARMA INC | $0 | – | -8,748,629 | -100.0% | -0.73% | – |
| Exit | THIRD HARMONIC BIO INC | $0 | – | -4,365,933 | -100.0% | -0.75% | – | |
| ETNB | Exit | 89BIO INC | $0 | – | -1,846,154 | -100.0% | -0.77% | – |
| CGEM | Exit | CULLINAN ONCOLOGY INC | $0 | – | -3,196,701 | -100.0% | -0.78% | – |
| Exit | ROIVANT SCIENCES LTD | $0 | – | -2,742,409 | -100.0% | -0.86% | – | |
| REPL | Exit | REPLIMUNE GROUP INC | $0 | – | -2,143,036 | -100.0% | -0.99% | – |
| Exit | ZYMEWORKS INC | $0 | – | -5,870,000 | -100.0% | -1.00% | – | |
| Exit | TYRA BIOSCIENCES INC | $0 | – | -2,739,595 | -100.0% | -1.02% | – | |
| JANX | Exit | JANUX THERAPEUTICS INC | $0 | – | -4,579,818 | -100.0% | -1.24% | – |
| ACRS | Exit | ACLARIS THERAPEUTICS INC | $0 | – | -7,064,736 | -100.0% | -1.30% | – |
| FDMT | Exit | 4D MOLECULAR THERAPEUTICS IN | $0 | – | -4,007,413 | -100.0% | -1.38% | – |
| XOMA | Exit | XOMA CORP DEL | $0 | – | -3,633,743 | -100.0% | -1.38% | – |
| CNTA | Exit | CENTESSA PHARMACEUTICALS PLCsponsored ads | $0 | – | -9,103,054 | -100.0% | -1.59% | – |
| KURA | Exit | KURA ONCOLOGY INC | $0 | – | -6,730,983 | -100.0% | -1.66% | – |
| XENE | Exit | XENON PHARMACEUTICALS INC | $0 | – | -1,827,958 | -100.0% | -1.68% | – |
| MRUS | Exit | MERUS N V | $0 | – | -2,752,420 | -100.0% | -1.75% | – |
| KYMR | Exit | KYMERA THERAPEUTICS INC | $0 | – | -4,739,004 | -100.0% | -1.78% | – |
| GLPG | Exit | GALAPAGOS NVspon adr | $0 | – | -1,915,109 | -100.0% | -1.78% | – |
| PNT | Exit | POINT BIOPHARMA GLOBAL INC | $0 | – | -10,563,748 | -100.0% | -1.90% | – |
| Exit | STRUCTURE THERAPEUTICS INCsponsored ads | $0 | – | -1,750,000 | -100.0% | -2.38% | – | |
| GHRS | Exit | GH RESEARCH PLCordinary shares | $0 | – | -9,275,158 | -100.0% | -2.51% | – |
| PTGX | Exit | PROTAGONIST THERAPEUTICS INC | $0 | – | -5,744,848 | -100.0% | -2.58% | – |
| RPTX | Exit | REPARE THERAPEUTICS INC | $0 | – | -8,291,988 | -100.0% | -2.70% | – |
| RVMD | Exit | REVOLUTION MEDICINES INC | $0 | – | -3,981,212 | -100.0% | -2.97% | – |
| OLMA | Exit | OLEMA PHARMACEUTICALS INC | $0 | – | -9,135,893 | -100.0% | -3.04% | – |
| MIRM | Exit | MIRUM PHARMACEUTICALS INC | $0 | – | -4,370,024 | -100.0% | -3.72% | – |
| IDYA | Exit | IDEAYA BIOSCIENCES INC | $0 | – | -5,283,489 | -100.0% | -3.84% | – |
| AXSM | Exit | AXSOME THERAPEUTICS INC | $0 | – | -2,131,100 | -100.0% | -4.02% | – |
| IONS | Exit | IONIS PHARMACEUTICALS INC | $0 | – | -4,004,613 | -100.0% | -4.90% | – |
| Exit | MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $0 | – | -21,751,284 | -100.0% | -33.43% | – |
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| XENON PHARMACEUTICALS INC | 36 | Q3 2023 | 4.7% |
| PIERIS PHARMACEUTICALS INC | 30 | Q3 2023 | 2.8% |
| CYTOKINETICS INC | 29 | Q4 2020 | 11.8% |
| INFINITY PHARMACEUTICALS INC | 29 | Q2 2023 | 4.3% |
| XOMA CORP DEL | 28 | Q3 2023 | 7.3% |
| ARQULE INC | 27 | Q4 2019 | 4.8% |
| CHEMOCENTRYX INC | 26 | Q3 2019 | 13.8% |
| CYTOMX THERAPEUTICS INC | 26 | Q3 2023 | 5.3% |
| CORVUS PHARMACEUTICALS INC | 26 | Q3 2023 | 2.3% |
| ARRAY BIOPHARMA INC | 25 | Q2 2019 | 14.5% |
View BVF INC/IL's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 4 | 2024-05-13 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-01-29 |
| 3 | 2024-01-26 |
| 4 | 2024-01-09 |
| 4 | 2023-12-20 |
| 4 | 2023-11-17 |
| 13F-HR | 2023-11-14 |
| 3 | 2023-11-13 |
View BVF INC/IL's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.